Serina Therapeutics Inc
(SER)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||
| Net Income | -235 | -6,580 |
| Depreciation Amortization | 122 | 699 |
| Accounts receivable | 53 | N/A |
| Other Working Capital | 374 | 776 |
| Other Operating Activity | -2,319 | -1,180 |
| Operating Cash Flow | $-2,005 | $-6,285 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -1 | -1 |
| Sale Of Investment | 3,215 | N/A |
| Other Investing Activity | -800 | 6 |
| Investing Cash Flow | $2,414 | $5 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 737 | 13,275 |
| Financing Cash Flow | $737 | $13,275 |
| Exchange Rate Effect | -1 | 121 |
| Beginning Cash Position | 7,375 | 259 |
| End Cash Position | 8,520 | 7,375 |
| Net Cash Flow | $1,145 | $7,116 |
| Free Cash Flow | ||
| Operating Cash Flow | -2,005 | -6,285 |
| Capital Expenditure | -1 | N/A |
| Free Cash Flow | -2,006 | -6,285 |